Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Cowen & Co. Downgrades Sumo Logic to Market Perform

Cowen & Co. Downgrades Sumo Logic to Market Perform

Cowen & Co. analyst Derrick Wood downgrades Sumo Logic (NASDAQ:SUMO) from Outperform to Market Perform.

byBenzinga Newsdesk

February 15, 2023

1 minute read

Cowen & Co. analyst Derrick Wood downgrades Sumo Logic (NASDAQ:SUMO) from Outperform to Market Perform.

IQVIA Study Demonstrates Cost And Time Savings Of Decentralized Trials

By Benzinga Newsdesk

September 7, 8:30 AM

The study found faster, less expensive, and more engaging trials can be achieved using tech-enabled decentralized clinical trial models

IQV

Genworth Financial Q4 EPS $0.33 Beats $0.20 Estimate

By Bill Haddad

February 6, 5:20 PM

Genworth Financial (NYSE:GNW) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.20 by 65 percent. This is a 3.13 percent increase over earnings of $0.32 per share from the

GNW

Acurx Pharmaceuticals Stock Is Plummeting After Biotech Publishes Phase 2 Results

By Vandana Singh

November 2, 12:12 PM

Acurx Pharmaceuticals Inc (NASDAQ: ACXP) shares are trading lower after the company

ACXP

$100 Invested In Monolithic Power Systems 15 Years Ago Would Be Worth This Much Today

By Benzinga Insights

August 9, 5:00 PM

Monolithic Power Systems (NASDAQ:MPWR) has outperformed the market over the past 15 years by 13.36% on an annualized…

MPWR

Cowen & Co. Downgrades Sumo Logic to Market Perform

Related Posts

IQVIA Study Demonstrates Cost And Time Savings Of Decentralized Trials

Genworth Financial Q4 EPS $0.33 Beats $0.20 Estimate

Acurx Pharmaceuticals Stock Is Plummeting After Biotech Publishes Phase 2 Results

$100 Invested In Monolithic Power Systems 15 Years Ago Would Be Worth This Much Today